Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001562180-25-002779)

Filing Details

Accession Number:: 0001562180-25-002779
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-03-27 16:40:54
Reporting Period:: 2025-03-25

Filing Date:: 2025-03-27
Accepted Time:: 2025-03-27 16:40:54
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1678660	Prelude Therapeutics Inc	PRLD	Pharmaceutical Preparations (2834)	811384762

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1825005	Andrew Combs	C/O Prelude Therapeutics Incorporated 175 Innovation Boulevard Wilmington DE 19805	Chief Chemistry Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-03-25	100,000	$0.69	480,123	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The reported total includes 2,500 shares of common stock the reporting person has acquired since the date of his last ownership report through the issuer's Employee Stock Purchase Plan in one or more transactions exempt pursuant to Rules 16b-3(c).